InvestorsHub Logo
Followers 7
Posts 299
Boards Moderated 0
Alias Born 01/07/2010

Re: F1ash post# 125605

Saturday, 10/21/2017 4:31:22 PM

Saturday, October 21, 2017 4:31:22 PM

Post# of 462048
F1ash, useful DD. Another one would be VTVT's compound currently in a late P3 and the next one on deck for readout in AZ space. Their approach of modulation of the RAGE pathway may improve mitochondrial damage. (Not your typical targeting of abeta aggregation or tau tangles.)
I haven't done enough digging to have a stake in this. Ron Perelman is a huge stakeholder. (PS: Moderators, I'm long & strong AVXL & not looking to get bashed / deleted.)
http://www.sciencedirect.com/science/article/pii/S0891584917307281


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News